World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
100
Citations
36097
World Ranking
727
National Ranking
415

Medicine

D-Index
100
Citations
36105
World Ranking
8289
National Ranking
4289

Thomas A. Fleisher publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Thomas A. Fleisher sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 338 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Thomas A. Fleisher D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Thomas A. Fleisher sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 100 D-Index — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2015 - Presidential Award, Clinical Immunology Society
  • 2009 - Distinguished Service Award, Clinical Immunology Society

Overview

Thomas A. Fleisher is affiliated with the National Institutes of Health in the United States. The scientist's research intersects multiple disciplines within medicine and immunology, focusing extensively on immunodeficiency and autoimmune disorders as well as blood-related diseases and hormone regulation.

The main fields of study include:

  • Medicine
  • Immunology and Microbiology

Specific subfields of study include:

  • Immunology
  • Endocrinology, Diabetes and Metabolism
  • Public Health, Environmental and Occupational Health
  • Hematology
  • Genetics

The principal topics explored in their work are:

  • Immunodeficiency and Autoimmune Disorders
  • Acute Lymphoblastic Leukemia research
  • Acute Myeloid Leukemia Research
  • Blood disorders and treatments
  • Cystic Fibrosis Research Advances
  • Adrenal Hormones and Disorders
  • Cytokine Signaling Pathways and Interactions

Recent publications authored or co-authored include:

  • "Germline IKAROS dimerization haploinsufficiency causes hematologic cytopenias and malignancies," 2020, published in Blood
  • "Diagnostic tests for primary immunodeficiency disorders: Classic and genetic testing," 2024, published in Allergy and Asthma Proceedings
  • "Cushing syndrome and glucocorticoids: T-cell lymphopenia, apoptosis, and rescue by IL-21," 2021, published in Journal of Allergy and Clinical Immunology
  • "An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome," 2020, published in UNC Libraries
  • "Systematic functional validation of IKAROS variants from patients and laboratory-generated mutations," 2025, published in Blood Advances

Frequent co-authors collaborating with Thomas A. Fleisher include:

  • Sergio D. Rosenzweig
  • Hye Sun Kuehn
  • Julie E. Niemela
  • Jennifer Stoddard
  • Kaan Boztuğ

Their contributions have been disseminated through several publication venues, notably:

  • Blood
  • Allergy and Asthma Proceedings
  • Journal of Allergy and Clinical Immunology
  • UNC Libraries
  • Blood Advances

Thomas A. Fleisher has received recognition in the form of awards such as the Presidential Award from the Clinical Immunology Society in 2015 and the Distinguished Service Award from the same society in 2009.

Best Publications

  • T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years

    R. Michael Blaese;Kenneth W. Culver;A. Dusty Miller;Charles S. Carter

  • Activated STING in a Vascular and Pulmonary Syndrome

    Y. Liu;A.A. Jesus;B. Marrero;D. Yang

  • Age, thymopoiesis, and CD4+ t-lymphocyte regeneration after intensive chemotherapy

    Crystal L. Mackall;Thomas A. Fleisher;Margaret R. Brown;Mary P. Andrich

  • Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4

    Hye Sun Kuehn;Weiming Ouyang;Bernice Lo;Elissa K. Deenick;Elissa K. Deenick

  • Early-Onset Stroke and Vasculopathy Associated with Mutations in ADA2

    Qing Zhou;Dan Yang;Amanda K Ombrello;Andrey V Zavialov

  • Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer

    Kevin C. Conlon;Enrico Lugli;Hugh C. Welles;Hugh C. Welles;Steven A. Rosenberg

  • Transplantation Outcomes for Severe Combined Immunodeficiency, 2000–2009

    Sung Yun Pai;Brent R. Logan;Linda M. Griffith;Rebecca H. Buckley

  • An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome

    Scott W. Canna;Adriana Almeida de Jesus;Sushanth Gouni;Stephen R. Brooks

  • Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency

    Carrie L Lucas;Hye Sun Kuehn;Fang Zhao;Julie E Niemela

  • Tocilizumab in systemic lupus erythematosus: data on safety, preliminary efficacy, and impact on circulating plasma cells from an open-label phase I dosage-escalation study

    Gabor G. Illei;Yuko Shirota;Cheryl H. Yarboro;Jimmy Daruwalla

  • The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.

    Stephen E. Straus;Elaine S. Jaffe;Jennifer M. Puck;Janet K. Dale

  • Flow cytometric analysis of the granulocyte respiratory burst: a comparison study of fluorescent probes.

    S.J. Vowells;S. Sekhsaria;H.L. Malech;M. Shalit

  • Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets

    Claude Sportès;Frances T. Hakim;Sarfraz A. Memon;Hua Zhang

  • Revised diagnostic criteria and classification for the autoimmune lymphoproliferative syndrome (ALPS): report from the 2009 NIH International Workshop.

    Joao B. Oliveira;Jack J. Bleesing;Umberto Dianzani;Thomas A. Fleisher

  • Clinical, Immunologic, and Genetic Features of an Autoimmune Lymphoproliferative Syndrome Associated With Abnormal Lymphocyte Apoptosis

    Michael C. Sneller;Jin Wang;Janet K. Dale;Warren Strober

  • A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells.

    T Uchiyama;D L Nelson;T A Fleisher;T A Waldmann

  • Distinctions Between CD8+ and CD4+ T-Cell Regenerative Pathways Result in Prolonged T-Cell Subset Imbalance After Intensive Chemotherapy

    Crystal L. Mackall;Thomas A. Fleisher;Thomas A. Fleisher;Margaret R. Brown;Margaret R. Brown;Mary P. Andrich;Mary P. Andrich

  • Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells

    Hua Zhang;Kevin S Chua;Martin Guimond;Veena Kapoor

  • Histamine Potently Suppresses Human IL-12 and Stimulates IL-10 Production via H2 Receptors

    Ilia J. Elenkov;Elizabeth Webster;Dimitris A. Papanicolaou;Thomas A. Fleisher

  • Lymphocyte depletion during treatment with intensive chemotherapy for cancer.

    Crystal L. Mackall;Thomas A. Fleisher;Margaret R. Brown;Ian T. Magrath

Frequent Co-Authors

Jennifer M. Puck
Jennifer M. Puck University of California, San Francisco
Thomas A. Waldmann
Thomas A. Waldmann National Institutes of Health
Sergio D. Rosenzweig
Sergio D. Rosenzweig National Institutes of Health
Stefania Pittaluga
Stefania Pittaluga National Institutes of Health
Luigi D. Notarangelo
Luigi D. Notarangelo National Institutes of Health
Sharon E. Straus
Sharon E. Straus University of Toronto
Harry L. Malech
Harry L. Malech National Institutes of Health
William T. Shearer
William T. Shearer Baylor College of Medicine
Jack J. Bleesing
Jack J. Bleesing Cincinnati Children's Hospital Medical Center
Rebecca H. Buckley
Rebecca H. Buckley Duke University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology opens doors to various healthcare and research careers, often requiring advanced nursing qualifications. For those interested in specializing within mental health, exploring the cheapest pmhnp programs online can be a cost-effective way to advance your education and serve unique patient populations.

Nurse practitioners aiming to deepen their expertise or shift focus might consider options like the acute care nurse practitioner certification. This specialization is crucial for treating critically ill patients and complements immunological knowledge in clinical settings.

To accelerate your career, researching the accelerated nurse practitioner programs can help you obtain credentials faster without sacrificing quality education. These programs often cater to those who already hold a nursing degree and want to advance rapidly.

Understanding dnp salary transparency is essential when planning your career. It allows you to make informed decisions based on potential earnings across states, helping you align your immunology expertise with viable financial outcomes.

Best Scientists Citing Thomas A. Fleisher

Trending Scientists

Recently Published Articles